Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected study content, indicating restricted access to the NCT04204928 record and a generic access-denied page is shown.SummaryDifference14%

- Check41 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a new build of the page. This change appears to reflect a minor, behind-the-scenes update rather than a modification to study details or user-facing content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the page for tracking purposes.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a new patch or update to the page or underlying system. This is a minor update and does not change the displayed study details or user-facing content.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a routine deployment update rather than a change to the study content.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, replacing the previous build indicator with a newer minor platform update.SummaryDifference0.1%

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.